Is Adicet Bio Inc (NASDAQ: ACET) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

ACET belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $3.38 and fluctuated between $3.4000 as its day high and $3.1250 as its day low. The current market capitalization of Adicet Bio Inc is $277.33M. A total of 1.66 million shares were traded on the day, compared to an average of 1.14M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ACET has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 9 SELLs from insiders. Insiders purchased 1,801,400 shares during that period but sold 81,399.

In the most recent transaction, ORBIMED ADVISORS LLC bought 3,125,000 shares of ACET for 2.40 per share on Jan 25. After the transaction, the Director now owns 7,526,359 company shares. In a previous transaction on Jan 25, GORDON CARL L bought 3,125,000 shares at 2.40 per share. ACET shares that Director owns now total 7,526,359.

Among the insiders who bought shares, Schor Chen acquired of 5,500 shares on Oct 02 at a per-share price of $1.33. This resulted in the President & CEO holding 43,469 shares of ACET after the transaction. In another insider transaction, Schor Chen sold 5,500 shares at $1.36 per share on Sep 29. Company shares held by the President & CEO now total 176,969.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ACET in the last 3 months, the mean price target is $9.60 with high estimates of $19.00 and low estimates of $5.00. In terms of 52-week highs and lows, ACET has a high of $8.69 and a low of $1.10.

As of this writing, ACET has an earnings estimate of -$0.7 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.45 per share and a lower estimate of -$0.78. The company reported an EPS of -$0.75 in the last quarter, which was -10.30% lower than expectations of -$0.68.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ACET’s latest balance sheet shows that the firm has $277.54M in Cash & Short Term Investments as of fiscal 2021. There were $20.94M in debt and $16.32M in liabilities at the time. Its Book Value Per Share was $4.52, while its Total Shareholder’s Equity was $303.13M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACET is Buy with a score of 4.40.

Most Popular

Related Posts